Hakim Djaballah

4.3k total citations · 1 hit paper
81 papers, 3.3k citations indexed

About

Hakim Djaballah is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hakim Djaballah has authored 81 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 23 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Hakim Djaballah's work include RNA Interference and Gene Delivery (13 papers), Peptidase Inhibition and Analysis (8 papers) and Computational Drug Discovery Methods (7 papers). Hakim Djaballah is often cited by papers focused on RNA Interference and Gene Delivery (13 papers), Peptidase Inhibition and Analysis (8 papers) and Computational Drug Discovery Methods (7 papers). Hakim Djaballah collaborates with scholars based in United States, United Kingdom and China. Hakim Djaballah's co-authors include Klaus Früh, Bhavneet Bhinder, Christophe Antczak, Pascal Sempé, Young Mok Yang, Robert Tampé, Kwangseog Ahn, Constantin Radu, David Shum and Peter Van Endert and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Hakim Djaballah

80 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A viral inhibitor of peptide transporters for antigen presentation

1995 509 citations Klaus Früh, Hakim Djaballah et al. profile →

Peers

Countries citing papers authored by Hakim Djaballah

Since Specialization

Citations

This map shows the geographic impact of Hakim Djaballah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakim Djaballah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakim Djaballah more than expected).

Fields of papers citing papers by Hakim Djaballah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakim Djaballah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakim Djaballah. The network helps show where Hakim Djaballah may publish in the future.

Co-authorship network of co-authors of Hakim Djaballah

This figure shows the co-authorship network connecting the top 25 collaborators of Hakim Djaballah. A scholar is included among the top collaborators of Hakim Djaballah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakim Djaballah. Hakim Djaballah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma 2021 ·Clinical Cancer Research ·Christina V. Angeles, (unknown), (unknown), (unknown), David Shum, Penelope D. Ruiz, (unknown), Irina Ostrovnaya, Rodrigo Gularte‐Mérida, Benjamin A. Nacev, Mark A. Dickson, Hakim Djaballah, Tomoyo Okada, Samuel Singer	10
2	ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells 2016 ·Scientific Reports ·(unknown), Alexander Pietras, Tatsuya Ozawa, Elena Bazzoli, Ondřej Podlaha, Christophe Antczak, Bengt Westermark, Sven Nelander, Lene Uhrbom, Karin Forsberg‐Nilsson, Hakim Djaballah, Franziska Michor, Eric C. Holland	44
3	A High-Content Assay Strategy for the Identification and Profiling of ABCG2 Modulators in Live Cells 2013 ·Assay and Drug Development Technologies ·Christophe Antczak, (unknown), Constantin Radu, Bhavneet Bhinder, Eric C. Holland, Hakim Djaballah	8
4	Combining integrated genomics and functional genomics to dissect the biology of a cancer‐associated, aberrant transcription factor, the ASPSCR1–TFE3 fusion oncoprotein 2013 ·The Journal of Pathology ·Rachel Kobos, Makoto Nagai, Masumi Tsuda, (unknown), Tsuyoshi Saito, Marick Laé, Qianxing Mo, Adam B. Olshen, (unknown), Christina C. Leslie, Irina Ostrovnaya, Christophe Antczak, Hakim Djaballah, Marc Ladanyi	50
5	Systematic Analysis of RNAi Reports Identifies Dismal Commonality at Gene-Level and Reveals an Unprecedented Enrichment in Pooled shRNA Screens 2013 ·Combinatorial Chemistry & High Throughput Screening ·Bhavneet Bhinder, Hakim Djaballah	25
6	An Arrayed RNA Interference Genome-Wide Screen Identifies Candidate Genes Involved in the MicroRNA 21 Biogenesis Pathway 2012 ·Assay and Drug Development Technologies ·David Shum, Bhavneet Bhinder, Christina N. Ramirez, Constantin Radu, (unknown), (unknown), Thalia A. Farazi, Markus Landthaler, (unknown), Susan Magdaleno, Hakim Djaballah	5
7	An Arrayed Genome-Scale Lentiviral-Enabled Short Hairpin RNA Screen Identifies Lethal and Rescuer Gene Candidates 2012 ·Assay and Drug Development Technologies ·Bhavneet Bhinder, Christophe Antczak, Christina N. Ramirez, David Shum, (unknown), Constantin Radu, Mark G. Frattini, Hakim Djaballah	10
8	Domain-Based Biosensor Assay to Screen for Epidermal Growth Factor Receptor Modulators in Live Cells 2012 ·Assay and Drug Development Technologies ·Christophe Antczak, Alun Bermingham, (unknown), Dmitry Malkov, Keming Song, John Fetter, Hakim Djaballah	27
9	A Simple Method for Analyzing Actives in Random RNAi Screens: Introducing the “H Score” for Hit Nomination & Gene Prioritization 2012 ·Combinatorial Chemistry & High Throughput Screening ·Bhavneet Bhinder, Hakim Djaballah	17
10	A High-Content Biosensor-Based Screen Identifies Cell-Permeable Activators and Inhibitors of EGFR Function: Implications in Drug Discovery 2012 ·SLAS DISCOVERY ·Christophe Antczak, (unknown), Bhavneet Bhinder, (unknown), Hakim Djaballah	25
11	A High-Throughput Scintillation Proximity-Based Assay for Human DNA Ligase IV 2011 ·Assay and Drug Development Technologies ·(unknown), David Shum, Bhavneet Bhinder, (unknown), Nicholas Veomett, Alan E. Tomkinson, David Y. Gin, Hakim Djaballah, David A. Scheinberg	13
12	A High-Throughput Screen for Alpha Particle Radiation Protectants 2010 ·Assay and Drug Development Technologies ·Jonathan Seideman, David Shum, Hakim Djaballah, David A. Scheinberg	9
13	High-Content Assay to Identify Inhibitors of Dengue Virus Infection 2010 ·Assay and Drug Development Technologies ·David Shum, Jessica L. Smith, Alec J. Hirsch, Bhavneet Bhinder, Constantin Radu, David A. Stein, Jay A. Nelson, Klaus Früh, Hakim Djaballah	70
14	Validation of a High-Content Screening Assay Using Whole-Well Imaging of Transformed Phenotypes 2010 ·Assay and Drug Development Technologies ·Christina N. Ramirez, Tatsuya Ozawa, Toshimitsu Takagi, Christophe Antczak, David Shum, Robert J. Graves, Eric C. Holland, Hakim Djaballah	13
15	A Miniaturized 1536-Well Format γ-Secretase Assay 2009 ·Assay and Drug Development Technologies ·Christopher C. Shelton, Yuan Tian, David Shum, Constantin Radu, Hakim Djaballah, Yue‐Ming Li	14
16	Development and Validation of a High-Density Fluorescence Polarization-Based Assay for the Trypanosoma RNA Triphosphatase TbCet1 2009 ·Combinatorial Chemistry & High Throughput Screening ·Christophe Antczak, David Shum, Constantin Radu, Venkatraman Seshan, Hakim Djaballah	11
17	Synthesis of Antiproliferative Cephalotaxus Esters and Their Evaluation against Several Human Hematopoietic and Solid Tumor Cell Lines: Uncovering Differential Susceptibilities to Multidrug Resistance 2008 ·Chemistry - A European Journal ·(unknown), (unknown), (unknown), (unknown), David Shum, Christophe Antczak, Leonid Tarassishin, Hakim Djaballah, David Y. Gin	58
18	A Profiling Platform for the Identification of Selective Metalloprotease Inhibitors 2008 ·SLAS DISCOVERY ·Christophe Antczak, Constantin Radu, Hakim Djaballah	18
19	A Homogenous 384-Well High Throughput Screen for Novel Tumor Necrosis Factor Receptor: Ligand Interactions Using Time Resolved Energy Transfer 1999 ·SLAS DISCOVERY ·(unknown), Sandra Turconi, (unknown), Hakim Djaballah, Pertti Hurskainen, (unknown), (unknown), (unknown)	24
20	Time-Resolved Fluorescence Energy Transfer DNA Helicase Assays for High Throughput Screening 1999 ·SLAS DISCOVERY ·David L. Earnshaw, Keith J. M. Moore, (unknown), Hakim Djaballah, Anthony J. Jurewicz, Kenneth Murray, Andrew J. Pope	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact